Grow Your Medical Technology Business Through Financing, M&A, and Strategic Partnerships
Elsevier Business Intelligence, the publishers of the "The Gray Sheet," IN VIVO, START-UP and MedTech Insight is pleased to announce IN3 Medical Device 360° Orlando.
This must-attend event will bring together investment leaders, emerging medtech company management teams, mid-sized and large device company business development teams, patent and copyright firms, regulatory officials and other noteworthy service providers for a full two days of start-up and investor presentations, private partnering meetings and key plenary/panel sessions.
Don't miss this year's program highlights:
-
Making the Pitch: What Do Dealmakers Want? (2 Parts)
In this interactive session, business development executives share their insights and perspectives based on actual company presentations, offering insights on what they like to see from smaller venture-backed companies.
-
Special Featured Panel Discussion for Medical Device Innovators
Angels, Grants and Venture Debt: Alternative Financing Strategies for those Seeking Funding in Today's Difficult Marketplace.
VC Meet & Greet: Network with Top VCs and Business Development Executives
If you are a VC and/or Business Development Executive, this is a must attend event. This session, through facilitated meetings, brings VCs and business development executives together to better understand each others' needs.
IN3 Medical Device 360° Orlando will benefit all players in the device space:
As an Early-, Mid- or Late-Stage Start-Up Seeking Investment or Partnership: Present to our audience of key decision makers in investment, corporate business development and venture capital, and advance your company to the next level.
As an Investor: Meet the management teams and hear pitches from more than 35 carefully selected, innovative start-ups poised to transform existing markets or create new ones.
As a Mid-Size Medical Device Company: Learn about key drivers and limiters to your growing business, meet potential partners to help you through clinical trials and onto the market, and assess acquisition targets.
As a Large Medical Device Company: Assess a myriad of opportunities to expand your company's portfolio and ensure a healthy pipeline in 2012 and beyond.
As a Service Provider: Gain exposure to innovators and market leaders who are seeking quality partners and outsourcing to bring their companies and products to the next level.
